Work

Risk-benefit of HMG-CoA reductase inhibitors in the treatment of HIV protease inhibitor-related hyperlipidaemia

Year: 2002

Type: review

Source: Expert Opinion on Drug Safety

DOI: 10.1517/14740338.1.1.5

Authors: Scott R Penzak, Susan K Chuck

Institutions: National Institutes of Health, National Institutes of Health Clinical Center, Grady Health System

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2163947715

FWCI: 0.552

Cites: 70

Cited by: 28

Related to: 10